Date: 21 -SEPTEMBER-2026 Last Updated: 21-SEPTEMBER-2026
Flunixin meglumine, a non-steroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic activity.
Introduction
Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic activity. Flunixin products are used in horses and cattle for applications involving the management of pain, inflammation, and fever associated with several veterinary conditions.
Its importance in veterinary medicine makes flunixin an analyte of interest for pharmaceutical quality control, formulation analysis, and analytical method development. Its aromatic structure also makes it an interesting candidate for evaluating the distinctive selectivity of the Cogent Phenyl Hydride™ stationary phase.
Peaks:
1. Flunixin meglumine
Method Conditions
Column:
Cogent Phenyl Hydride™, 4 μm, 100 Å
Catalog No.
:
69020-10P
Dimensions
: 4.6 x 100 mm
Mobile Phase
: 50:50 DI Water /
Acetonitrile /
0.1% formic acid
Injection vol.
: 1μL
Flow rate
: 1.0 mL/minute
Detection
: UV @ 254 nm
Sample Preparation
:
Flunixin
0.137 mg/mL diluted with 50:50 ACN:DI water.
Note:
Flunixin meglumine is widely recognized in veterinary medicine and is the active drug associated with Banamine® used for controlling pain, inflammation, and fever.
